Despite these strong effects on hepatic lipid content, SH42 did not affect fasting plasma glucose, insulin, or homeostatic Model Assessment for Insulin Resistance (HOMA‐IR) scores (Fig EV1H–J). This evidence concerns the gene INS and Insulin resistance.